These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue. Price B, Pyne NJ, Houslay MD. Biochem Pharmacol; 1987 Dec 01; 36(23):4047-54. PubMed ID: 2825712 [Abstract] [Full Text] [Related]
3. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds. de Cheffoy de Courcelles D, de Loore K, Freyne E, Janssen PA. J Pharmacol Exp Ther; 1992 Oct 01; 263(1):6-14. PubMed ID: 1328613 [Abstract] [Full Text] [Related]
5. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. Silver PJ, Lepore RE, O'Connor B, Lemp BM, Hamel LT, Bentley RG, Harris AL. J Pharmacol Exp Ther; 1988 Oct 01; 247(1):34-42. PubMed ID: 2845058 [Abstract] [Full Text] [Related]
6. Differential sensitivity to cardiotonic drugs of cyclic AMP phosphodiesterases isolated from canine ventricular and sinoatrial-enriched tissues. Komas N, Lugnier C, Le Bec A, Serradeil-Le Gal C, Barthélémy G, Stoclet JC. J Cardiovasc Pharmacol; 1989 Aug 01; 14(2):213-20. PubMed ID: 2476593 [Abstract] [Full Text] [Related]
7. Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone. Earl CQ, Linden J, Weglicki WB. J Cardiovasc Pharmacol; 1986 Aug 01; 8(4):864-72. PubMed ID: 2427830 [Abstract] [Full Text] [Related]
8. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism. Ahn HS, Eardley D, Watkins R, Prioli N. Biochem Pharmacol; 1986 Apr 01; 35(7):1113-21. PubMed ID: 2421728 [Abstract] [Full Text] [Related]
9. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle. Silver PJ, Harris AL, Canniff PC, Lepore RE, Bentley RG, Hamel LT, Evans DB. J Cardiovasc Pharmacol; 1989 Apr 01; 13(4):530-40. PubMed ID: 2470989 [Abstract] [Full Text] [Related]
12. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Komas N, Lugnier C, Stoclet JC. Br J Pharmacol; 1991 Oct 01; 104(2):495-503. PubMed ID: 1665741 [Abstract] [Full Text] [Related]
19. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria. Muller B, Lugnier C, Stoclet JC. J Cardiovasc Pharmacol; 1990 Mar 01; 15(3):444-51. PubMed ID: 1691369 [Abstract] [Full Text] [Related]
20. Mechanism of action and cardiotonic activity of a new phosphodiesterase inhibitor, the benzimidazole derivative adibendan (BM 14.478), in guinea-pig hearts. Bethke T, Brunkhorst D, von der Leyen H, Meyer W, Nigbur R, Scholz H. Naunyn Schmiedebergs Arch Pharmacol; 1988 May 01; 337(5):576-82. PubMed ID: 2457816 [Abstract] [Full Text] [Related] Page: [Next] [New Search]